Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Locantore

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Expert Opinion on Drug Discovery|October 27, 2021
Discovery, preclinical development, and clinical application of pralsetinib in the treatment of thyroid cancerPietro Locantore, Roberto Novizio, Andrea Corsello, et al.
Biomedicines|December 2, 2020
Medical Approaches in Adrenocortical CarcinomaRosa Maria Paragliola, Andrea Corsello, Pietro Locantore, et al.
Expert Opinion on Drug Discovery|August 20, 2016
Mouse models of medullary thyroid cancer and developing new targeted therapiesRosa Maria Paragliola, Francesco Torino, Giampaolo Papi, et al.
European Endocrinology|October 24, 2018
Role of Mitotane in Adrenocortical Carcinoma - Review and State of the artRosa Maria Paragliola, Francesco Torino, Giampaolo Papi, et al.
International Journal of Molecular Sciences|November 9, 2024
Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized ManagementGianluca Cera, Andrea Corsello, Roberto Novizio, et al.
Frontiers in Endocrinology|March 19, 2019
Factors Predicting Time to TSH Normalization and Persistence of TSH Suppression After Total Thyroidectomy for Graves' DiseaseRosa Maria Paragliola, Vincenzo Di Donna, Pietro Locantore, et al.
Frontiers in Endocrinology|February 18, 2021
Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency PatientsFrancesca Delle Cese, Andrea Corsello, Marco Cintoni, et al.
Cancers|January 21, 2023
Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell CarcinomaRosa Maria Paragliola, Francesco Torino, Agnese Barnabei, et al.
Hormones (Athens, Greece)|August 22, 2012
Assessment of salivary free cortisol levels by liquid chromatography with tandem mass spectrometry (LC-MS/MS) in patients treated with mitotaneCinzia Carrozza, Rosa Lapolla, Jacopo Gervasoni, et al.
Diseases (Basel, Switzerland)|January 24, 2025
Hypercalcemia Following Adrenalectomy for Cushing Syndrome in a Patient with Post-Surgical HypoparathyroidismPietro Locantore, Alessandro Oliva, Gianluca Cera, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Discovery|October 27, 2021
Discovery, preclinical development, and clinical application of pralsetinib in the treatment of thyroid cancerPietro Locantore, Roberto Novizio, Andrea Corsello, et al.
Biomedicines|December 2, 2020
Medical Approaches in Adrenocortical CarcinomaRosa Maria Paragliola, Andrea Corsello, Pietro Locantore, et al.
Expert Opinion on Drug Discovery|August 20, 2016
Mouse models of medullary thyroid cancer and developing new targeted therapiesRosa Maria Paragliola, Francesco Torino, Giampaolo Papi, et al.
European Endocrinology|October 24, 2018
Role of Mitotane in Adrenocortical Carcinoma - Review and State of the artRosa Maria Paragliola, Francesco Torino, Giampaolo Papi, et al.
International Journal of Molecular Sciences|November 9, 2024
Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized ManagementGianluca Cera, Andrea Corsello, Roberto Novizio, et al.
Frontiers in Endocrinology|March 19, 2019
Factors Predicting Time to TSH Normalization and Persistence of TSH Suppression After Total Thyroidectomy for Graves' DiseaseRosa Maria Paragliola, Vincenzo Di Donna, Pietro Locantore, et al.
Frontiers in Endocrinology|February 18, 2021
Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency PatientsFrancesca Delle Cese, Andrea Corsello, Marco Cintoni, et al.
Cancers|January 21, 2023
Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell CarcinomaRosa Maria Paragliola, Francesco Torino, Agnese Barnabei, et al.
Hormones (Athens, Greece)|August 22, 2012
Assessment of salivary free cortisol levels by liquid chromatography with tandem mass spectrometry (LC-MS/MS) in patients treated with mitotaneCinzia Carrozza, Rosa Lapolla, Jacopo Gervasoni, et al.
Diseases (Basel, Switzerland)|January 24, 2025
Hypercalcemia Following Adrenalectomy for Cushing Syndrome in a Patient with Post-Surgical HypoparathyroidismPietro Locantore, Alessandro Oliva, Gianluca Cera, et al.
Pageof 5